UK biotech startup takes aim at weight loss leaders Novo, Lilly
admin 3 days agoUSA UpdateComments Off on UK biotech startup takes aim at weight loss leaders Novo, Lilly3 Views
A UK biotechnology startup is entering the crowded obesity drug market, armed with $US411 million ($664.2m) and a promising next-generation weight-loss pill.
